Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
29%

OVERLAP
BY WEIGHT
18

# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
64%
ALSO IN BBP
BBP
67
HOLDINGS
29%
ALSO IN PBE
SECTOR DRIFT (PBE minus BBP)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in BBP
Overlap
DYNAVAX TECHNOLOGIES CORP 2.5% 2.2% 2.2%
BIOMARIN PHARMACEUTICAL INC 2.5% 1.7% 1.7%
HALOZYME THERAPEUTICS INC 2.4% 1.7% 1.7%
EXELIXIS INC 2.7% 1.7% 1.7%
REGENERON PHARMACEUTICALS 4.8% 1.6% 1.6%
PBE Overweight Relative to BBP
ILLUMINA INC 4.8%
ROYALTY PHARMA PLC CLASS A 4.7%
BIOGEN IDEC INC 3.9%
VERTEX PHARMACEUTICALS INC 3.3%
INCYTE CORP 3.2%
AMGEN INC 3.2%
VERACYTE INC 3.2%
REGENERON PHARMACEUTICALS 3.2%
EXACT SCIENCES CORP 3.1%
GILEAD SCIENCES INC 3.0%
PBE Underweight Relative to BBP
AMICUS THERAPEUTICS INC -2.1%
IOVANCE BIOTHERAPEUTICS INC -1.9%
AXSOME THERAPEUTICS, INC. -1.9%
MIRUM PHARMACEUTICALS, INC. -1.9%
PHATHOM PHARMACEUTICALS, INC. -1.8%
DAY ONE BIOPHARMACEUTICALS, INC. -1.7%
TRAVERE THERAPEUTICS, INC. -1.7%
NUVATION BIO INC CLASS A -1.7%
THERAVANCE BIOPHARMA INC -1.6%
SYNDAX PHARMACEUTICALS INC -1.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY